These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 36677775)
1. Solving an Old Puzzle: Elucidation and Evaluation of the Binding Mode of Salvinorin A at the Kappa Opioid Receptor. Puls K; Wolber G Molecules; 2023 Jan; 28(2):. PubMed ID: 36677775 [TBL] [Abstract][Full Text] [Related]
2. Elucidation of conformational states, dynamics, and mechanism of binding in human κ-opioid receptor complexes. Leonis G; Avramopoulos A; Salmas RE; Durdagi S; Yurtsever M; Papadopoulos MG J Chem Inf Model; 2014 Aug; 54(8):2294-308. PubMed ID: 25060329 [TBL] [Abstract][Full Text] [Related]
3. Discovery of Novel, Selective, and Nonbasic Agonists for the Kappa-Opioid Receptor Determined by Salvinorin A-Based Virtual Screening. Puls K; Olivé-Marti AL; Hongnak S; Lamp D; Spetea M; Wolber G J Med Chem; 2024 Aug; 67(16):13788-13801. PubMed ID: 39088801 [TBL] [Abstract][Full Text] [Related]
5. Mechanistic Characterization of the Pharmacological Profile of HS-731, a Peripherally Acting Opioid Analgesic, at the µ-, δ-, κ-Opioid and Nociceptin Receptors. Puls K; Schmidhammer H; Wolber G; Spetea M Molecules; 2022 Jan; 27(3):. PubMed ID: 35164182 [TBL] [Abstract][Full Text] [Related]
6. Michael acceptor approach to the design of new salvinorin A-based high affinity ligands for the kappa-opioid receptor. Polepally PR; Huben K; Vardy E; Setola V; Mosier PD; Roth BL; Zjawiony JK Eur J Med Chem; 2014 Oct; 85():818-29. PubMed ID: 25193297 [TBL] [Abstract][Full Text] [Related]
7. O6C-20-nor-salvinorin A is a stable and potent KOR agonist. Hirasawa S; Cho M; Brust TF; Roach JJ; Bohn LM; Shenvi RA Bioorg Med Chem Lett; 2018 Sep; 28(16):2770-2772. PubMed ID: 29426768 [TBL] [Abstract][Full Text] [Related]
8. Comparison of pharmacological activities of three distinct kappa ligands (Salvinorin A, TRK-820 and 3FLB) on kappa opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo. Wang Y; Tang K; Inan S; Siebert D; Holzgrabe U; Lee DY; Huang P; Li JG; Cowan A; Liu-Chen LY J Pharmacol Exp Ther; 2005 Jan; 312(1):220-30. PubMed ID: 15383632 [TBL] [Abstract][Full Text] [Related]
9. Differential helical orientations among related G protein-coupled receptors provide a novel mechanism for selectivity. Studies with salvinorin A and the kappa-opioid receptor. Vortherms TA; Mosier PD; Westkaemper RB; Roth BL J Biol Chem; 2007 Feb; 282(5):3146-56. PubMed ID: 17121830 [TBL] [Abstract][Full Text] [Related]
10. Molecular Interaction Between Butorphanol and κ-Opioid Receptor. Ji J; Lin W; Vrudhula A; Xi J; Yeliseev A; Grothusen JR; Bu W; Liu R Anesth Analg; 2020 Sep; 131(3):935-942. PubMed ID: 32701545 [TBL] [Abstract][Full Text] [Related]
11. Immediate and Persistent Effects of Salvinorin A on the Kappa Opioid Receptor in Rodents, Monitored In Vivo with PET. Placzek MS; Van de Bittner GC; Wey HY; Lukas SE; Hooker JM Neuropsychopharmacology; 2015 Dec; 40(13):2865-72. PubMed ID: 26058662 [TBL] [Abstract][Full Text] [Related]
12. The analgesic and anti-inflammatory effects of Salvinorin A analogue β-tetrahydropyran Salvinorin B in mice. Paton KF; Kumar N; Crowley RS; Harper JL; Prisinzano TE; Kivell BM Eur J Pain; 2017 Jul; 21(6):1039-1050. PubMed ID: 28158929 [TBL] [Abstract][Full Text] [Related]
13. N-methylacetamide analog of salvinorin A: a highly potent and selective kappa-opioid receptor agonist with oral efficacy. Béguin C; Potter DN; Dinieri JA; Munro TA; Richards MR; Paine TA; Berry L; Zhao Z; Roth BL; Xu W; Liu-Chen LY; Carlezon WA; Cohen BM J Pharmacol Exp Ther; 2008 Jan; 324(1):188-95. PubMed ID: 17951511 [TBL] [Abstract][Full Text] [Related]
14. A unique binding epitope for salvinorin A, a non-nitrogenous kappa opioid receptor agonist. Kane BE; Nieto MJ; McCurdy CR; Ferguson DM FEBS J; 2006 May; 273(9):1966-74. PubMed ID: 16640560 [TBL] [Abstract][Full Text] [Related]
15. Toward a structure-based model of salvinorin A recognition of the kappa-opioid receptor. Kane BE; McCurdy CR; Ferguson DM J Med Chem; 2008 Mar; 51(6):1824-30. PubMed ID: 18293909 [TBL] [Abstract][Full Text] [Related]
17. Identification of the molecular mechanisms by which the diterpenoid salvinorin A binds to kappa-opioid receptors. Yan F; Mosier PD; Westkaemper RB; Stewart J; Zjawiony JK; Vortherms TA; Sheffler DJ; Roth BL Biochemistry; 2005 Jun; 44(24):8643-51. PubMed ID: 15952771 [TBL] [Abstract][Full Text] [Related]
18. Structure-based design, synthesis, and biochemical and pharmacological characterization of novel salvinorin A analogues as active state probes of the kappa-opioid receptor. Yan F; Bikbulatov RV; Mocanu V; Dicheva N; Parker CE; Wetsel WC; Mosier PD; Westkaemper RB; Allen JA; Zjawiony JK; Roth BL Biochemistry; 2009 Jul; 48(29):6898-908. PubMed ID: 19555087 [TBL] [Abstract][Full Text] [Related]
19. Chemical syntheses of the salvinorin chemotype of KOR agonist. Hill SJ; Brion AUCM; Shenvi RA Nat Prod Rep; 2020 Nov; 37(11):1478-1496. PubMed ID: 32808003 [TBL] [Abstract][Full Text] [Related]
20. A review of salvinorin analogs and their kappa-opioid receptor activity. Roach JJ; Shenvi RA Bioorg Med Chem Lett; 2018 May; 28(9):1436-1445. PubMed ID: 29615341 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]